Human Tissue Kallikreins as Promiscuous Modulators of Homeostatic Skin Barrier Functions

    May 2008 in “ Biological Chemistry
    Azza Eissa, Eleftherios P. Diamandis
    TLDR Human tissue kallikreins help regulate skin barrier functions and affect skin health.
    The document reviewed the roles of human tissue kallikreins (KLKs), a family of serine protease endopeptidases, in skin barrier functions. It highlighted that KLKs, particularly KLK5 and KLK7, were initially recognized for their proteolytic activity in the skin, but recent findings suggested broader roles through proteolytic activation cascades. These enzymes were proposed to modulate various skin functions, including desquamation, antimicrobial defense, and lipid permeability. Additionally, evidence indicated their involvement in skin inflammation, pigmentation, and tumor suppression by targeting proteinase-activated receptor signaling pathways. The review summarized the current understanding of KLKs in skin physiology and pathobiology.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Fresh off the press: Dutasteride may cause chronic infertility

      in Research/Science  643 upvotes 8 months ago
      Dutasteride may cause chronic infertility by reducing semen volume and motility, with concerns about irreversible prostate fibrosis. Users consider switching to finasteride or using treatments like minoxidil and microneedling, weighing hair preservation against fertility.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    1 / 1 results